Efficacy of botulinum toxin vs corticosteroid in the management of persistent post-surgical scar pain

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518954-18-01

Enrollment

Registered

2024-12-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-surgical scar pain

Brief summary

Numerical rating scale of pain (NRS)

Detailed description

b. Brief pain inventory score (short form) (BPI-sf) c. Pain self-efficacy questionnaire (PSEQ) d. Documentation of any adverse events e. Patients global impression of change (PGIC)

Interventions

DRUGBupivacaine 2.5mg/ml Solution for Injection

DRUGBOTOX 100 Allergan Units Powder for Solution for Injection

DRUGAdcortyl™ Intra-articular / Intradermal Injection 10 mg/ml

DRUGSuspension for Injection

DRUG5 ml

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Numerical rating scale of pain (NRS)	—

Secondary

Measure	Time frame
b. Brief pain inventory score (short form) (BPI-sf) c. Pain self-efficacy questionnaire (PSEQ) d. Documentation of any adverse events e. Patients global impression of change (PGIC)	—

Countries

Ireland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026